Under zinc-deficient conditions, wild-type SOD1 undergoes conformational changes resembling mutant SOD1, exposing a Derlin-1-binding region that disrupts ERAD 124,125
This asymmetric dual engagement is intended to expand the therapeutic window, mitigate GLP-1driven tolerability limits, enable higher effective chronic dosing, and translate into more durable weight loss with robust glycemic control versus pure GLP-1 agonists
If youre taking diabetes medications, please discuss this with your prescribing doctor before starting Rybelsus, as your diabetes medications may need to be adjusted as you lose weight
Is it time to change the way we report and discuss weight loss
How do incretin-based multi-agonists like tirzepatide and retatrutide work
Compared to other commonly prescribed treatments: Wegovy tablets average ~17% weight loss over 71 weeks